Please login to the form below

Not currently logged in
Email:
Password:

Professor Thomas Cech joins Storm Therapeutics

He takes up a scientific advisor role at the group

Thomas CechStorm Therapeutics, a company focused on the discovery of small molecule therapies has appointed Professor Thomas Cech as its scientific advisor.

Professor Cech’s career has seen him spend decades researching into RNA biology and he became the scientific founder of Ribozyme Pharmaceuticals. He currently serves on the board of directors of Merck & Co.

Commenting on the new appointments, Keith Blundy, chief executive officer of Storm Therapeutics, said: “We are very pleased to have attracted such an internationally renowned researcher as Professor Cech to Storm.

“As a leader in the field of RNA biology, Tom’s in-depth knowledge, insight and experience will be invaluable as we look to continue building a drug discovery platform and mature into a world leading therapeutics company targeting RNA epigenetic modulation.”

His new role will see him join recent hires Professor Mark Dawson and Dr Paul Leeson to boost Storm’s pipeline.

9th February 2018

From: Sales

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Blue Latitude Health

Blue Latitude Health is a creative marketing consultancy. Founded in 2003, our combination of heritage, approach and capability gives us...

Latest intelligence

Delivering true value: what does it mean for KAM in cancer care?
Lisa Alderson, Business Development Director at Wilmington Healthcare, explores the challenges that pharma’s KAM teams face in engaging with the NHS and how they must evolve...
Pharma M&A
Pharma funding and M&A in 2020
Why pharma M&A has continually bucked the trend...
Behaviour change through medical education: How can we turn aspiration into reality?
Practical, evidence-based insights into a CME process that aims to effect measurable behaviour change...

Infographics